^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners

TEST:
Caris ChromoSeq

Type:
Laboratory Developed Test
Related tests:
Evidence

News

1m
Caris Life Sciences Receives MolDX Approval for Caris ChromoSeq, Advancing Access to Comprehensive Genomic Profiling for Myeloid Malignancies (Caris Life Sciences Press Release)
''Caris Life Sciences®...today announced that Caris ChromoSeq™ has received MolDX approval, a key milestone supporting broader clinical access to Caris’ comprehensive whole genome tumor profiling assay for myeloid malignancies.''
Clinical
|
Caris ChromoSeq